(Q44358651)

2 December 2017

title

Increase of haemoglobin levels by anti-retroviral therapy is associated with a decrease in immune activation (English)

1 reference

2 December 2017

3

1 reference

2 December 2017

Mario Sarcletti

1

1 reference

2 December 2017

Gisela Quirchmair

series ordinal

2

1 reference

2 December 2017

Dietmar Fuchs

series ordinal

4

1 reference

2 December 2017

Robert Zangerle

series ordinal

5

1 reference

2 December 2017

publication date

1 January 2003

1 reference

European Journal of Haematology

2 December 2017

published in

1 reference

2 December 2017

volume

70

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

17-25

1 reference

Anemia and survival in HIV infection

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

Predictors of survival in HIV-infected persons with 50 or fewer CD4 cells/mm3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

HIV-associated hematologic disorders are correlated with plasma viral load and improve under highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

7 January 2021

Anemia and human immunodeficiency virus disease in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

7 January 2021

Epoetin alfa therapy for anaemia in HIV-infected patients: impact on quality of life

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

7 January 2021

Predicting outcomes in HIV-infected veterans: I. Progression to AIDS.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

7 January 2021

Estimation of survival after AIDS diagnosis: CD4 T lymphocyte count versus clinical severity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

7 January 2021

Long-term survival in patients with advanced immunodeficiency

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

7 January 2021

Human immunodeficiency virus infection, anemia, and survival

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

7 January 2021

A Clinically Prognostic Scoring System for Patients Receiving Highly Active Antiretroviral Therapy: Results from the EuroSIDA Study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

7 January 2021

Pathogenesis and pathophysiology of anemia in HIV infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

7 January 2021

Absent or rare human immunodeficiency virus infection of bone marrow stem/progenitor cells in vivo

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

7 January 2021

Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

7 January 2021

Host factors and the pathogenesis of HIV-induced disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

7 January 2021

Increased concentrations of soluble tumor necrosis factor receptor 75 but not of soluble intercellular adhesion molecule-1 are associated with the decline of CD4+ lymphocytes in HIV infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

7 January 2021

Influence of human recombinant interferon-alpha and interferon-gamma on bone marrow progenitor cells of HIV-positive individuals.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

7 January 2021

Association between immune activation, changes of iron metabolism and anaemia in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

7 January 2021

Reversal of human immunodeficiency virus type 1-associated hematosuppression by effective antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

7 January 2021

Parallel decrease in neurotoxin quinolinic acid and soluble tumor necrosis factor receptor p75 in serum during highly active antiretroviral therapy of HIV type 1 disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

7 January 2021

Immunologic effects of combined protease inhibitor and reverse transcriptase inhibitor therapy in previously treated chronic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

7 January 2021

Combination antiretroviral therapy including a protease inhibitor eliminated the transfusion requirements of HIV-infected individuals with anemia of chronic disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

7 January 2021

Iron status and indicators of human immunodeficiency virus disease severity among pregnant women in Malawi

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

7 January 2021

Bone marrow macrophage iron grade and survival of HIV-seropositive patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

7 January 2021

Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

7 January 2021

Linkage of cell-mediated immunity to iron metabolism

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

7 January 2021

Tumor necrosis factor alpha and soluble tumor necrosis factor receptors in individuals with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

7 January 2021

Improved antioxidant status among HIV-infected injecting drug users on potent antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

7 January 2021

Beneficial effects of protease inhibitors on body composition and energy expenditure: a comparison between HIV-infected and AIDS patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.02810.X

7 January 2021

10.1034/J.1600-0609.2003.02810.X

Identifiers

DOI

1 reference

2 December 2017

1 reference